PHOTO
Abu Dhabi: National Reference Laboratory (NRL), part of Mubadala’s network of world-class healthcare providers, today announced that it has signed a Laboratory Referral Services Agreement with United Eastern Medical Services (UEMedical) Group, one of Abu Dhabi's leading private healthcare operators.
NRL will become the exclusive provider of referral laboratory testing to all facilities of the UEMedical healthcare network in the UAE, including its flagship hospital Danat Al Emarat for Women & Children, HealthPlus Network of Specialty Centers, HealthPlus Fertility Centers and Moorfields Eye Hospital Abu Dhabi. Patients of UEMedical network will benefit from NRL’s high-quality standards, specialized logistics solutions and comprehensive menu of more than 4,700 tests, one of the largest test menus globally thanks to NRL’s partnership with LabCorp, the world’s leading diagnostics company.
Abdulla Abdul Aziz Al Shamsi, Head of Mubadala Healthcare, said: “Mubadala has built a network of world-class healthcare providers and we are continuously looking for opportunities to partner with private healthcare providers. This partnership allows us to deliver better results and outcomes for the patients, to provide unified laboratory services across all healthcare facilities of UEMedical, and, ultimately, to have a positive impact on the healthcare sector across the country and the region.”
Commenting on the collaboration, Mohammed Ali Al Shorafa Al Hammadi, CEO & Managing Director of UEMedical, said: “As one of the emirate’s leading healthcare providers, our partnership NRL, one of the most experienced providers of laboratory solutions in the region, will complement our group laboratory department with additional services and improved deliverables. NRL’s expertise will be very well received by our network of physicians and patients, who are eager to gain access to best-in-class laboratory referral services. This collaboration will help us make another significant stride towards achieving our goals to provide the highest levels of care to the residents of the UAE and support the nation’s healthcare transition to innovative, patient-centric services.”
Patient samples from all of UEMedical’s facilities across the UAE will now be exclusively handled by NRL and tested either in-country by NRL or by LabCorp in the USA.
Abdul Hamid Oubeisi, Chief Executive Officer of NRL, added: “We are very pleased that UEMedical has agreed to partner exclusively with NRL for laboratory referral services. This new partnership further demonstrates the trust that healthcare providers place in our services and quality. We look forward to providing UEMedical’s facilities with advanced, best-in-class laboratory diagnostic services across a wide range of disciplines, ensuring optimum and seamless treatment journeys for all their patients.”
Majd Abu Zant, Chief Operating Officer of UEMedical said, "Across our different facilities in the UAE, we serve over 200,000 patients who will be benefiting from our collaboration with NRL offering now the full
spectrum of laboratory tests complementing the performed tests in our in-house laboratory. We are indeed joining hands today to deliver high end diagnostic services to the community of Abu Dhabi and beyond."
NRL’s robust logistics solutions will guarantee sample integrity and timely sample transport from UEMedical’s facilities across the UAE, and will deliver reliable and fast test results. Additionally, best-practice connectivity solutions, including a web-portal and a two-way real-time interface between NRL’s Laboratory Information System and the Electronic Medical Records (EMR) of UEMedical, will ensure an accurate and efficient process for test ordering and results delivery. This paper-less system will help reduce the risk of human error and work duplication, and will greatly enhance quality and patient outcomes. Via the interface connection, physicians will be able to access and order from NRL’s comprehensive test menu 24/7. Laboratory results will be reported in real-time and automatically stored in each patient’s unique EMR.
NRL operates the largest network of laboratories in the Middle East accredited by the College of American Pathologists (CAP), widely recognized globally as the leading accreditation body for clinical laboratories. Its network of laboratories in the UAE encompasses a total of 10 facilities, including two reference laboratories owned by NRL and 8 on-site laboratories managed by NRL on behalf of its hospital or medical center clients. In addition, NRL offers referral testing services to a host of clients in the country and the region.
-Ends-
About Mubadala Investment Company
Mubadala Investment Company actively manages a worldwide portfolio supporting the vision of a globally integrated and diversified economy, through sustainable returns to its shareholder, the Government of Abu Dhabi. In March 2018, Abu Dhabi Investment Council (ADIC) joined the Group.
Mubadala’s US $225 billion (AED 830 dirham) portfolio spans five continents with interests in aerospace, ICT, semiconductors, metals and mining, renewable energy, oil and gas, petrochemicals, utilities, healthcare, real estate, defense services, pharmaceuticals and medical technology, agribusiness and a global portfolio of financial holdings. Mubadala is a trusted partner, an engaged shareholder and a responsible global company that is committed to ethics and world-class standards. For more information about Mubadala, please visit: www.mubadala.com
About National Reference Laboratory
National Reference Laboratory (NRL) is a Mubadala company created in partnership with and managed by LabCorp, a leading global life sciences company providing comprehensive clinical laboratory services. NRL’s vision is to increase the spectrum, coverage and overall efficiency of laboratory testing, to implement international best practice reference laboratory processes and to set the benchmark for quality standards in the region.
Together with the significant resources of LabCorp, NRL offers a comprehensive menu of more than 4,700 tests, providing a complete solution for all clinical testing needs in an efficient and high-quality environment that reduces both turnaround time and logistics-related costs, compared with other laboratories. The diverse and growing network of NRL currently includes eleven owned and managed laboratories across the UAE. For more information, please visit www.nrl.ae.
About LabCorp
LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $11 billion in 2018 to learn more about LabCorp, visit www.labcorp.com, and to learn more about Covance Drug Development, visit www.covance.com.
About United Eastern Medical Services (UEMedical) Group
United Eastern Medical Services (UEMedical) is the leading Healthcare Development & Investment Company in Abu Dhabi. Since its inception in 2005, UEMedical has continuously raised the standards of medical services across the Emirate and the region with its world-class specialty hospitals and outpatient facilities. By partnering with a number of internationally renowned healthcare providers, UEMedical excels in delivering advanced healthcare solutions. UEMedical consists of over 72 different facilities in Abu Dhabi, Dubai and Saudi Arabia, and employs over 3,000 healthcare professionals across the group.
UEMedical’s portfolio includes:
· The flagship, Danat Al Emarat Hospital for Women & Children, Abu Dhabi
· HealthPlus Network of Specialty Centers, Abu DHbai
· HealthPlus Fertility Centers, in Abu Dhabi, Dubai and KSA
· Moorfields Eye Hospital Abu Dhabi
· Al Muhaidib Dental Group, KSA
Through the participation and support of key stakeholders, UEMedical is committed to developing and managing an integrated healthcare delivery system comprising world-class specialty hospitals, outpatient health centers and healthcare support services throughout the region.
For more information, please visit www.uems.ae
Media Contacts:
Salma Chalak, Consultant, Wallis PR
Telephone: +0971 58 982 9525
Email: salma.chalak@wallispr.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
